Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 5872865, 6 pages
https://doi.org/10.1155/2018/5872865
Research Article

Deferoxamine but Not Dimethyloxalylglycine, L-Mimosine, or Cobalt Dichloride Can Interfere with the MTT Assay

1Department of Conservative Dentistry and Periodontology, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria
2Austrian Cluster for Tissue Regeneration, Vienna, Austria
3Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria
4Department of Oral Surgery, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria

Correspondence should be addressed to Hermann Agis; ta.ca.neiwinudem@siga.nnamreh

Received 8 May 2018; Revised 11 September 2018; Accepted 26 September 2018; Published 18 November 2018

Academic Editor: Evandro Piva

Copyright © 2018 Anna Sonja Müller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Müller, K. Janjić, B. Lilaj, M. Edelmayer, and H. Agis, “Hypoxia-based strategies for regenerative dentistry—Views from the different dental fields,” Archives of Oral Biolog, vol. 81, pp. 121–130, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Fraisl, J. Aragonés, and P. Carmeliet, “Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease,” Nature Reviews Drug Discovery, vol. 8, no. 2, pp. 139–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Agis, G. Watzek, and R. Gruber, “Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts,” Journal of Periodontal Research, vol. 47, no. 2, pp. 165–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Duscher, M. Januszyk, Z. N. Maan et al., “Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing,” Plastic and Reconstructive Surgery, vol. 139, no. 3, pp. 695–706, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Duscher, E. Neofytou, V. W. Wong et al., “Transdermal deferoxamine prevents pressure-induced diabetic ulcers,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 112, no. 1, pp. 94–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Yuan, P. Wang, L. Zhu et al., “Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro,” Tissue Engineering Part A, vol. 21, no. 5-6, pp. 1163–1172, 2015. View at Publisher · View at Google Scholar
  7. L. Jiang, W. W. Peng, and L. F. Li, “Effects of deferoxamine on the repair ability of dental pulp cells in vitro,” Journal of Endodontics, vol. 40, no. 8, pp. 1100–1104, 2014. View at Publisher · View at Google Scholar
  8. H.-D. Müller, B. Cvikl, R. Gruber, G. Watzek, and H. Agis, “Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells,” Journal of Endodontics, vol. 38, no. 11, pp. 1498–1503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Shen, C. Wan, G. Ramaswamy et al., “Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice,” Journal of Orthopaedic Research, vol. 27, no. 10, pp. 1298–1305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Donneys, S. S. Deshpande, C. N. Tchanque-Fossuo et al., “Deferoxamine expedites consolidation during mandibular distraction osteogenesis,” Bone, vol. 55, no. 2, pp. 384–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Donneys, A. S. Farberg, C. N. Tchanque-Fossuo, S. S. Deshpande, and S. R. Buchman, “Deferoxamine enhances the vascular response of bone regeneration in mandibular distraction osteogenesis,” Plastic and Reconstructive Surgery, vol. 129, no. 4, pp. 850–856, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Kuchler, C. Keibl, A. Fügl et al., “Dimethyloxalylglycine lyophilized onto bone substitutes increase vessel area in rat calvarial defects,” Clinical Oral Implants Research, vol. 26, no. 5, pp. 485–491, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Agis, L. Hueber, N. Pour Sadeghian, M. Pensch, and R. Gruber, “In vitro release kinetic of dimethyloxaloylglycine and l-mimosine from bovine bone mineral,” Archives of Oral Biolog, vol. 59, no. 10, pp. 1024–1031, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Al-Habbal, K. Janjić, M. Edelmayer, A. Moritz, and H. Agis, “Collagen barrier membranes do not adsorb hypoxia mimetic activity-Activity of gingival fibroblasts cultured directly on collagen barrier membranes loaded with hypoxia mimetic agents,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 106, no. 2, pp. 874–879, 2018. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Hamid, M. Pensch, and H. Agis, “Release kinetics of prolyl hydroxylase inhibitors from collagen barrier membranes,” Journal of Biomaterials Applications, vol. 29, no. 8, pp. 1059–1067, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Caballé-Serrano, K. Sawada, R. J. Miron, D. D. Bosshardt, D. Buser, and R. Gruber, “Collagen barrier membranes adsorb growth factors liberated from autogenous bone chips,” Clinical Oral Implants Research, vol. 28, no. 2, pp. 236–241, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. D. F. Williams, “On the mechanisms of biocompatibility,” Biomaterials, vol. 29, no. 20, pp. 2941–2953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. F. Williams, “There is no such thing as a biocompatible material,” Biomaterials, vol. 35, no. 38, pp. 10009–10014, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Riss, R. A. Moravec, A. L. Niles et al., “Cell Viability Assays,” in Assay Guidance Manual. Eli Lilly Company and the National Center for Advancing Translational Sciences, G. S. Coussens, N. P. Nelson, H. Arkin et al., Eds., Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD), 2004. View at Google Scholar
  20. P. Vinzenz, S. Schröckmair, R. Gruber, and H. Agis, “Bone substitute materials supplemented with prolyl hydroxylase inhibitors decrease osteoclastogenesis in vitro,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 103, no. 6, pp. 1198–1203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Edelmayer, D. Al-Habbal, M. Pensch, K. Janjic, and H. Agis, “Effect of prolyl hydroxylase inhibitor-loaded collagen barrier membranes on osteoclastogenesis and osteoblastogenesis,” Journal of Biomaterials Applications, vol. 31, no. 10, pp. 1370–1379, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Schlueter, A. Lussi, C. Ganss, and R. Gruber, “L929 fibroblast bioassay on the in vitro toxicity of SnCl2, H3PO4, Clearfil SE primer and combinations thereof,” Swiss Dental Journal, vol. 126, no. 6, pp. 566–572, 2016. View at Google Scholar · View at Scopus
  23. B. Kandler, P. Maitz, M. B. Fischer, G. Watzek, and R. Gruber, “Platelets can neutralize hydrogen peroxide in an acute toxicity model with cells involved in granulation tissue formation,” Bone, vol. 36, no. 4, pp. 671–677, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Cvikl, A. Lussi, and R. Gruber, “The in vitro impact of toothpaste extracts on cell viability,” European Journal of Oral Sciences, vol. 123, no. 3, pp. 179–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. ISO 10993-5:2009. Biological evaluation of medical devices.